Navigation Links
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
Date:10/6/2008

More than 60 percent of moderate to severe patients achieved endoscopic response and more than 40 percent achieved endoscopic remission at Week 10 in data from a 54-week open-label study presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting

ORLANDO, Fla., Oct. 6 /PRNewswire/ -- UCB today presented data from a large, prospective study investigating endoscopic improvement in Crohn's disease (CD) with a biologic compound. The data presented at the American College of Gastroenterology Annual Scientific Meeting demonstrates that CIMZIA(R) (certolizumab pegol) -- the only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) -- significantly improved endoscopic lesions and induced endoscopic response (as assessed by the Crohn's Disease Endoscopic Index of Severity (CDEIS)) within ten weeks of treatment in more than 60 percent of the moderate to severe Crohn's disease patients studied.

"Even though the study was uncontrolled, it is interesting to see evidence of endoscopic improvement so early in the course of treatment," said lead study investigator Jean-Frederic Colombel, M.D., Hepatogastroenterology, CHRU Lille, the Regional Hospital Center of the University of Lille, France. "Long-term follow up of these patients will allow us to determine the clinical impact of endoscopic improvement on modifying the course of the disease."

Data from the 54-week, open-label Phase IIIb MUSIC trial showed significant improvement by Week 10 in CDEIS scores, the primary endpoint of the study. Scores dropped from 14.7 to 8.2 -- a reduction of 6.5 points, or 44 percent improvement compared to baseline. The CDEIS, which ranges from 0 to 44 points, is used to assess the presence of mucosal lesions associated with inflammation along the lining of the gut (ileum, colon and rectum). Mucosal healing has been associated with a lower rate of hospitalization and lower need for surgery.

Improvements in secondary endpoints, including
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
2. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
3. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
4. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
7. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
8. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
9. CV Therapeutics Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
10. Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
11. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ) ... Canaccord Genuity 35th Annual Growth Conference on Wednesday, August ... Boston Hotel.  A webcast of the ... are encouraged to visit the web site at least ... to register, download and install any necessary software.  The ...
(Date:7/30/2015)... , July 30, 2015  Cleave Biosciences ... Trademark Office has granted the company a key ... Cleave,s lead molecule CB-5083. This newly ... inhibitors of p97," U.S. 9,062,026, allows for claims ... first-in-class, highly selective oral inhibitor of p97, a ...
(Date:7/30/2015)... 30, 2015 Flexpoint Ford, a private equity ... today announced that it has entered into a partnership ... to form Kastle Therapeutics, LLC (Kastle).  The new ... focus on acquiring, developing and commercializing pharmaceuticals targeted toward ... include select therapies already approved for marketing, as well ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... Alsius Corporation,(Nasdaq: ALUS ), the worldwide leader ... four scientific,posters featuring both patient cases and laboratory ... be presented this week at the American,Society of ... Dr. Arie Blitz, Director of Heart Transplantation ...
... Trial Results Disclosed, SAN DIEGO, Oct. ... developing "Best-in-Class" drugs for the,treatment of serious ... multiple studies on its lead program, TR-701, ... in eighteen presentations at the upcoming joint,Interscience ...
Cached Medicine Technology:Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 2Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 3Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 2Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 3
(Date:7/31/2015)... Raton, FL (PRWEB) , ... July 31, 2015 ... ... marketing and distribution of a wide variety of nutritional and wellness products, announced ... neuromuscular therapist that specializes in massage therapy, active isolated stretching and the prevention ...
(Date:7/31/2015)... ... July 31, 2015 , ... People love to ... disability insurance, where price is an important factor to clients when choosing to ... carrier, offers the Preferred Producer Multi-Life Discount program, where advisers pass savings onto ...
(Date:7/30/2015)... ... ... Dale Sky Jones, Executive Chancellor of Oaksterdam University , the first cannabis ... at the Caribe Royal All Suites Hotel and Convention Center in Orlando, Florida, October ... medical cannabis expo in the country and this year’s expo will be the first ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Committed to ... to action by asking community members to contribute to the College’s “My Brother’s Keeper ... of our young people stay on track. Providing the support they need to think ...
(Date:7/30/2015)... ... ... OSF Healthcare System has been recognized as one of the nation’s ... & Health Networks. This marks the fourth consecutive year for this achievement by the ... Third Order of St. Francis . , Health data security and patient engagement are ...
Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... Wellness through Education and Research InitiativesNEW YORK, April ... as a leadership contributor with the National Thoroughbred ... partnership,s aim is to ensure the health and ... accreditation program are addressed in a manner that ...
... Attention to Connecticut,s Growing Burden of Chronic Disease and Promote ... by CrisisHARTFORD, Conn., April 6 National and state health ... launch a Partnership to call for comprehensive health and economic ... in Connecticut and across the nation. , , ...
... Studies will chart recovery of active women with breast ... -- A Yale professor has received $7 million in ... ovarian and breast cancer recovery. , The U.S. ... that exercise along with traditional courses of treatment can ...
... identifies a protein that modifies the androgen receptor (AR) and ... progression of prostate cancer. The research, published by Cell Press ... Cell , may also drive creation of new strategies for ... to traditional anti-hormone therapies. , The AR is an ...
... joke that gets all the laughs. As funny as folks ... That,s one conclusion of a groundbreaking new paper from the ... the University of Toronto,s Rotman School of Management and the ... authors looked at the effect of sexual behavior in the ...
... is sweeping the countryCORDOVA, Tenn., April 6 Christian Companion ... practical and spiritual assistance, is opening an office in Cordova, ... The new office is located at 1160 Vickery Lane, Suite ... 1:30 p.m. and will last until 3:30 p.m. Free refreshments ...
Cached Medicine News:Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 3Health News:Bipartisan CT Coalition Forms to Fight Spiraling Health Care Costs 2Health News:Yale Plans Closer Look at Exercise and Cancer 2Health News:A potential new target for treatment of hormone refractory prostate cancer 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: